Cargando…

Antithrombotic drugs for cardiovascular risk reduction in patients with lower limb peripheral arterial disease: protocol for a systematic review and network meta-analysis of randomised controlled trials

INTRODUCTION: The optimal antithrombotic regimen to reduce the risk of vascular events in patients with peripheral arterial disease (PAD) is contentious. This systematic review and network meta-analysis (NMA) aims to define the relative efficacy and risks of previously investigated antithrombotic me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sidebottom, David Brooke, Huang, Chao, Carradice, Daniel, Holt, Peter J, John-Pierre, Karen, Roy, Iain Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423790/ https://www.ncbi.nlm.nih.gov/pubmed/37562931 http://dx.doi.org/10.1136/bmjopen-2023-072355

Ejemplares similares

Antithrombotic Treatment in Lower Extremity Peripheral Arterial Disease
por: Gottsäter, Anders
Publicado: (2021)

Antithrombotic therapy in peripheral arterial disease
por: Espinola-Klein, Christine, et al.
Publicado: (2022)

Antithrombotic regimens in females with symptomatic lower extremity peripheral arterial disease: protocol for a systematic review and meta-analysis
por: Strauss, Shira A, et al.
Publicado: (2021)

Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials
por: Mak, Koon-Hou
Publicado: (2012)

Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)
por: Cayton, Thomas, et al.
Publicado: (2017)

Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019)

Association of sex and cardiovascular risk factors with atherosclerosis distribution pattern in lower extremity peripheral artery disease
por: Baretella, Oliver, et al.
Publicado: (2023)

Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials
por: Zhu, Houyong, et al.
Publicado: (2023)

Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement
por: Verstraete, Andreas, et al.
Publicado: (2021)

Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
por: Sim, Martha M. S., et al.
Publicado: (2023)

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
por: Motloch, Lukas J., et al.
Publicado: (2022)

Spatial inequalities of major lower limb amputation rates in Paraná state, Brazil
por: Franco, Rogério do Lago, et al.
Publicado: (2020)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience
por: Zhu, Yuansong, et al.
Publicado: (2022)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

Task shifting interventions for cardiovascular risk reduction in low-income and middle-income countries: a systematic review of randomised controlled trials
por: Ogedegbe, Gbenga, et al.
Publicado: (2014)

Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial
por: Sotomi, Yohei, et al.
Publicado: (2021)

Case Report: An Unusual Case of Acute Lower Limb Ischemia as Precursor of the Asherson's Syndrome
por: Pasqui, Edoardo, et al.
Publicado: (2021)

Hyperglycemia may increase deep vein thrombosis in trauma patients with lower limb fracture
por: Liu, Xiaojie, et al.
Publicado: (2022)

Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation
por: Siller-Matula, Jolanta M., et al.
Publicado: (2020)

Predictive value of 10-year atherosclerotic cardiovascular disease risk equations from the China-PAR for new-onset lower extremity peripheral artery disease
por: He, Pengkang, et al.
Publicado: (2022)

A Very Rare Cause of Lower Limb Ischemia in Young People: Popliteal Artery Entrapment
por: Altinsoy, Hasan Baki, et al.
Publicado: (2018)

Evidence from Cochrane systematic reviews for effects of antithrombotic drugs for lower-limb revascularization. A narrative review
por: Dias, Silfayner Victor Mathias, et al.
Publicado: (2021)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Lipid‐lowering treatment patterns in patients with new cardiovascular events – estimates from population‐based register data in Sweden
por: Hallberg, S., et al.
Publicado: (2016)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?
por: Laborante, Renzo, et al.
Publicado: (2022)

Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease
por: Stivalet, Olivier, et al.
Publicado: (2021)

Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial
por: Garrison, Scott R, et al.
Publicado: (2022)

Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry
por: Olesen, Kevin Kris Warnakula, et al.
Publicado: (2021)

Antihyperglycemic Medications and Cardiovascular Risk Reduction
por: Anderson, Sarah L, et al.
Publicado: (2017)

Exaggerated postural sway improves orthostatic cardiovascular and cerebrovascular control
por: Williams, Erin L., et al.
Publicado: (2023)

Favorable Cardiovascular Health Is Associated With Lower Hepatocyte Growth Factor Levels in the Multi-Ethnic Study of Atherosclerosis
por: Osibogun, Olatokunbo, et al.
Publicado: (2022)

Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
por: Deng, Chang-Jiang, et al.
Publicado: (2023)

Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study
por: Pan, Tianyue, et al.
Publicado: (2022)

Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
por: Olasinska-Wisniewska, Anna, et al.
Publicado: (2019)

Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention
por: Liu, Hangkuan, et al.
Publicado: (2021)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rhcmp02t3is206teqsid8gn0u0